Subject: Nature Biotechnology Contents: April 2007 Volume 25 pp. 363 - 482

From: "Nature Biotechnology Alert"<[email-masked]>
Date: Tue, 10 Apr 2007 15:52:31 -0400 (EDT)

| | NATURE.COM | | [email-masked] | | NATUREJOBS | | NATUREEVENTS | | ABOUT NPG |

|

SEARCH | | |

April 2007, Volume 25 No 4

| In This Issue

| Editorial

| News: In Brief | News Feature

| Bioentrepreneur: Building a business

| Opinion and Comment: Correspondence | Commentary | Book Review

| Features: Patents

| News and Views

| Computational Biology: Commentary

| Research: Brief Communications | Articles | Letter | Errata | Corrigenda

| Naturejobs: Careers and Recruitment | People

This alert is supported by
Exiqon

MicroRNA Expression Profiling Service

• Speed up your research
• use Exiqon’s time and expertise
• Use less sample
• no need for miRNA enrichment
• Get reliable results
• miRNA profiles generated using
miRCURY™ LNA Arrays

This alert is supported by Roche Applied Science

LightCycler® 480 Real-Time PCR System
Looking for more versatility for real-time PCR applications?
We have what you need to accomplish more…
now and in the future.

Learn more about the cutting-edge technologies of the LightCycler® 480 System that provide versatility without compromise.
Visit www.lightcycler480.com today!

Nature at BIO International Convention

Stay abreast of (and contribute to!) the news, research and gossip unfolding at BIO International Convention through Nature Publishing Group’s interactive networking tools. Check out our conference blog, daily podcast, and the new Nature Network Boston website to see what we have to say and let us know what you think. Visit us at BIO International Convention in Boston May 7-9 at booth 2522, or online at www.nature.com/conferences.

In This Issue

Top

PDF

Editorial

Top

Sacrificing the cash cow p363

doi:10.1038/nbt0407-363

Abstract | Full Text | PDF

News

Top

Pharma consolidates its grip on post-antibody landscape pp365 - 366

Cormac Sheridan

doi:10.1038/nbt0407-365

Abstract | Full Text | PDF

US courts thwart GM alfalfa and turf grass p367

Jeffrey L. Fox

doi:10.1038/nbt0407-367

Abstract | Full Text | PDF

UK parses merits of value-based drug pricing pp369 - 370

Nuala Moran

doi:10.1038/nbt0407-369

Abstract | Full Text | PDF

Genentech faces the consequences of growth p371

John Ransom

doi:10.1038/nbt0407-371

Abstract | Full Text | PDF

In Brief

News in brief pp373 - 374

doi:10.1038/nbt0407-373

Full Text | PDF

Profile: John Maraganore pp375 - 376

Brady Huggett

doi:10.1038/nbt0407-375

Abstract | Full Text | PDF

News Feature

Making money and opening minds pp377 - 379

Monya Baker

doi:10.1038/nbt0407-377

Abstract | Full Text | PDF

Billion dollar babies[mdash]biotech drugs as blockbusters pp380 - 382

Stacy Lawrence

doi:10.1038/nbt0407-380

Abstract | Full Text | PDF

Bioentrepreneur

Top

Building a business

Key ingredients for success in Europe pp383 - 385

Colin Garner, Tony Marchington & Andrea Pfeifer

doi:10.1038/bioent917

PDF

Opinion and Comment

Top

Correspondence

WARF's licensing policy for ES cell lines pp387 - 388

Carl Gulbrandsen

doi:10.1038/nbt0407-387

Full Text | PDF

Gene patents[mdash]more evidence needed, but policymakers must act pp388 - 389

E Richard Gold, Tania Bubela, Fiona A Miller, Dianne Nicol & Tina Piper

doi:10.1038/nbt0407-388

Full Text | PDF

Nanobiotech versus synthetic nanotech? pp389 - 390

Mari Tabuchi

doi:10.1038/nbt0407-389

Full Text | PDF

Systems biology standards[mdash]the community speaks pp390 - 391

Edda Klipp, Wolfram Liebermeister, Anselm Helbig, Axel Kowald & Jorg Schaber

doi:10.1038/nbt0407-390

Full Text | PDF

Incentivizing standards development and adoption pp391 - 392

Fiona Reddington, J Max Wilkinson, Robin Clark & Richard H Begent

doi:10.1038/nbt0407-391

Full Text | PDF

Commentary

Commercializing cognitive neurotechnology[mdash]the ethical terrain pp393 - 397

Margaret L Eaton & Judy Illes

doi:10.1038/nbt0407-393

Abstract | Full Text | PDF

Research sharing, ethics and public benefit pp398 - 401

Patrick L Taylor

doi:10.1038/nbt0407-398

Abstract | Full Text | PDF

Book Review

Seduced by stem cells p402

Reviewed by: Laura DeFrancesco

doi:10.1038/nbt0407-402

Full Text | PDF

Features

Top

India's health biotech sector at a crossroads pp403 - 417

Sarah E Frew, Rahim Rezaie, Stephen M Sammut, Monali Ray, Abdallah S Daar & Peter A Singer

doi:10.1038/nbt0407-403

Abstract | Full Text | PDF

Patents

The global stem cell patent landscape: implications for efficient technology transfer and commercial development pp419 - 424

Karl Bergman & Gregory D. Graff

doi:10.1038/nbt0407-419

Abstract | Full Text | PDF

Recent patent applications in proteomics p425

doi:10.1038/nbt0407-425

Full Text | PDF

News and Views

Top

Towards universal red blood cells pp427 - 428

Geoff Daniels & Stephen G Withers

doi:10.1038/nbt0407-427

Abstract | Full Text | PDF

See also: Research by Liu et al.

Antibiotic production from the ground up pp428 - 429

Leonard Katz & Chaitan Khosla

doi:10.1038/nbt0407-428

Abstract | Full Text | PDF

See also: Research by Oliynyk et al.

Tagging the rice transcriptome pp430 - 431

Antoni Rafalski

doi:10.1038/nbt0407-430

Abstract | Full Text | PDF

See also: Research by Nobuta et al.

Vascular targeting via caveolae pp431 - 432

Kristy Red-Horse & Napoleone Ferrara

doi:10.1038/nbt0407-431

Abstract | Full Text | PDF

Lessons from the 1918 influenza pp433 - 434

Maria Zambon

doi:10.1038/nbt0407-433

Abstract | Full Text | PDF

Research Highlights p435

doi:10.1038/nbt0407-435

Full Text | PDF

Computational Biology

Top

Commentary

Overhauling the PDB pp437 - 442

Amanda C Schierz, Larisa N Soldatova & Ross D King

doi:10.1038/nbt0407-437

Abstract | Full Text | PDF

Research

Top

Brief Communications

Reporter proteins for in vivo fluorescence without oxygen pp443 - 445

Thomas Drepper, Thorsten Eggert, Franco Circolone, Achim Heck, Ulrich Krausz, Jan-Karl Guterl, Marion Wendorff, Aba Losi, Wolfgang Gartner & Karl-Erich Jaeger

doi:10.1038/nbt1293

Abstract | Full Text | PDF

Articles

Complete genome sequence of the erythromycin-producing bacterium Saccharopolyspora erythraea NRRL23338 pp447 - 453

Markiyan Oliynyk, Markiyan Samborskyy, John B Lester, Tatiana Mironenko, Nataliya Scott, Shilo Dickens, Stephen F Haydock & Peter F Leadlay

doi:10.1038/nbt1297

Abstract | Full Text | PDF

See also: News and Views by Katz and Khosla

Bacterial glycosidases for the production of universal red blood cells pp454 - 464

Qiyong P Liu, Gerlind Sulzenbacher, Huaiping Yuan, Eric P Bennett, Greg Pietz, Kristen Saunders, Jean Spence, Edward Nudelman, Steven B Levery, Thayer White, John M Neveu, William S Lane, Yves Bourne, Martin L Olsson, Bernard Henrissat & Henrik Clausen

doi:10.1038/nbt1298

Abstract | Full Text | PDF

See also: News and Views by Daniels and Withers

An anti-infective peptide that selectively modulates the innate immune response pp465 - 472

Monisha G Scott, Edie Dullaghan, Neeloffer Mookherjee, Natalie Glavas, Matthew Waldbrook, Annick Thompson, Aikun Wang, Ken Lee, Silvana Doria, Pam Hamill, Jie Jessie Yu, Yuexin Li, Oreola Donini, M Marta Guarna, B Brett Finlay, John R North & Robert E W Hancock

doi:10.1038/nbt1288

Abstract | Full Text | PDF

Letter

An expression atlas of rice mRNAs and small RNAs pp473 - 477

Kan Nobuta, R C Venu, Cheng Lu, Andre Belo, Kalyan Vemaraju, Karthik Kulkarni, Wenzhong Wang, Manoj Pillay, Pamela J Green, Guo-liang Wang & Blake C Meyers

doi:10.1038/nbt1291

Abstract | Full Text | PDF

See also: News and Views by Rafalski

Errata

Erratum: Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung p478

Phil Oh, Per Borgstrom, Halina Witkiewicz, Yan Li, Bengt J Borgstrom, Adrian Chrastina, Koji Iwata, Kurt R Zinn, Richard Baldwin, Jacqueline E Testa & Jan E Schnitzer

doi:10.1038/nbt0407-478a

Full Text | PDF

Erratum: Incretin mimetics vie for slice of type 2 diabetes market p478

Catherine Shaffer

doi:10.1038/nbt0407-478b

Full Text | PDF

Erratum: Editorial. Bioethanol needs biotech now p478

doi:10.1038/nbt0407-478c

Full Text | PDF

Corrigenda

Corrigendum: Complete genome of the mutualistic, N2-fixing grass endophyte Azoarcus sp. strain BH72 p478

Andrea Krause, Adarsh Ramakumar, Daniela Bartels, Federico Battistoni, Thomas Bekel, Jens Boch, Melanie Bohm, Frauke Friedrich, Thomas Hurek, Lutz Krause, Burkhard Linke, Alice C McHardy, Abhijit Sarkar, Susanne Schneiker, Arshad Ali Syed, Rudolf Thauer, Frank-Jorg Vorholter, Stefan Weidner, Alfred Puhler, Barbara Reinhold-Hurek, Olaf Kaiser & Alexander Goesmann

doi:10.1038/nbt0407-478d

Full Text | PDF

Corrigendum: Genome sequence of the bioplastic-producing [ldquo]Knallgas[rdquo] bacterium Ralstonia eutropha H16 p478

Anne Pohlmann, Wolfgang Florian Fricke, Frank Reinecke, Bernhard Kusian, Heiko Liesegang, Rainer Cramm, Thomas Eitinger, Christian Ewering, Markus Potter, Edward Schwartz, Axel Strittmatter, Ingo Vosz, Gerhard Gottschalk, Alexander Steinbuchel, Barbel Friedrich & Botho Bowien

doi:10.1038/nbt0407-478e

Full Text | PDF

Corrigendum: Evolving symbiosis[mdash]venture capital and biotechnology p478

Terry C Bradford

doi:10.1038/nbt0407-478f

Full Text | PDF

Naturejobs

Top

Careers and Recruitment

Managing change in biotech: startup and growth pp479 - 480

Mary Ann Rafferty

doi:10.1038/nbt0407-479

Abstract | Full Text | PDF

People

People p482

doi:10.1038/nbt0407-482

Full Text | PDF

Top

Nature Protocols:
Nature Protocols is THE online resource for authoritative, peer-reviewed protocols. Ensure you stay up to date with the latest protocols in your discipline by signing up for your FREE e-alerts.

ADVERTISEMENT

| |

| | Biomedical Scientist | | Medical/Healthcare | | SRG | | United Kingdom |
| | |
| Laboratory Scientist | | Laboratory/Research | | SRG | | United Kingdom
| | |
| PhD studentship | | Cancer Research / Oncology|Cell Biology|Clinical Sciences|Experimental Medicine|Pathology| | | UCL | | London, United Kingdom WC
| | |
| Postdoctoral fellow in cancer research | | Cancer Research / Oncology| | | Emory University | | Atlanta, GA
| | |
| Associate Scientist - MB3773 | | | | SRG | | United Kingdom
| | |
| Associate Scientist III | | Biochemistry|Biological Sciences|Biotechnology|Chemistry|Molecular Biology| | | Invitrogen Corporation | | Madison, WI 53706
| | |

More Naturejobs

| |
| | | | | |

| |

| |

More Nature Products

More Nature Events

| |

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Nature Biotechnology. To purchase a subscription, please visit secure.nature.com/subscribe/nbt

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/myaccount
(You will need to log in to be recognised as a nature.com registrant)

For further technical assistance, please contact our registration department

For print subscription enquiries, please contact our subscription department

For other enquiries, please contact our customer feedback department

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

© 2007 Nature Publishing Group